Growth Metrics

Trinity Biotech (TRIB) Other Non-Current Liabilities (2022 - 2025)

Trinity Biotech's Other Non-Current Liabilities history spans 4 years, with the latest figure at $781000.0 for Q4 2025.

  • On a quarterly basis, Other Non-Current Liabilities rose 941.33% to $781000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $781000.0, a 941.33% increase, with the full-year FY2025 number at $781000.0, up 941.33% from a year prior.
  • Other Non-Current Liabilities hit $781000.0 in Q4 2025 for Trinity Biotech, down from $1.8 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for TRIB hit a ceiling of $2.0 million in Q2 2022 and a floor of $75000.0 in Q4 2024.
  • Historically, Other Non-Current Liabilities has averaged $1.3 million across 4 years, with a median of $1.5 million in 2023.
  • Biggest five-year swings in Other Non-Current Liabilities: crashed 85.74% in 2024 and later soared 941.33% in 2025.
  • Tracing TRIB's Other Non-Current Liabilities over 4 years: stood at $1.6 million in 2022, then tumbled by 66.48% to $526000.0 in 2023, then crashed by 85.74% to $75000.0 in 2024, then soared by 941.33% to $781000.0 in 2025.
  • Business Quant data shows Other Non-Current Liabilities for TRIB at $781000.0 in Q4 2025, $1.8 million in Q2 2025, and $75000.0 in Q4 2024.